Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Cancer Genetics Inc

(NASDAQ: CGIX)
Add to Portfolio
-0.07 (-1.63%)
as of Feb 19, 2020

Last 4.22
Change -0.07 (-1.63%)
Open 4.31
Prev. Close 4.29
Today's Range
4.17
4.55
52wk Range
2.00
9.88
Volume 29,164
Avg Volume 53,495
Sector SIC-8071 Services-Medical Laboratories

Perfomance Comparison

Name Today 3-Month 1-Year
CGIX -1.63% -23.41% -43.73%
DJIA +0.40% +6.03% +13.35%
S&P 500 +0.47% +8.62% +21.81%

Key Statistics

Annual EPS -8.03
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 9,510
Weighted Alpha -82.70
Standard Deviation -0.35
Profit Margin N/A
Beta 2.53

Growth Rates

YTD -29.19%
1-Year -42.80%
3-Year -94.16%
5-Year -98.37%

Opinion

Sell Hold Buy

Recent Headlines

Delcath Systems Elects Seasoned Finance and Capital

GlobeNewswire via COMTEX - 08:30AM EST
Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced that Elizabeth Czerepak, a financial executive and board member with experience in(full story)
ALT: 1.76 (+0.05), CGIX: 4.22 (-0.07), DCTH: 12.0000 (+2.4500)

Breakthrough Study Makes Cancer Detection Possible

PR Newswire via COMTEX - Wed Feb 05, 09:00AM EST
A new study by scientists from India, USA, and UK has presented clinical evidence for an innovative test that can detect clusters of cancer cells in the blood of asymptomatic individuals as a non-invasive screening and diagnostic (full story)
CGIX: 4.22 (-0.07)

Cancer Genetics Reports Third Quarter 2019 Financial

GlobeNewswire via COMTEX - Wed Nov 20, 08:00AM EST
Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced strategic, financial and operating results for the third quarter ended September 30, 2019.(full story)
CGIX: 4.22 (-0.07)

Cancer Genetics, Inc. Announces Strategic Transactions

GlobeNewswire via COMTEX - Thu Oct 24, 04:19PM EDT
Note Payment Received from Interpace Diagnostics Group, Inc.(full story)
CGIX: 4.22 (-0.07), IDXG: 9.09 (+0.14)